2025

Plano, TX, May 07, 2025 --(PR.com)-- Eminent Spine, a leader in spinal implant innovation, proudly announces that its revolutionary 3D Printed Titanium Pedicle Screw System has received FDA 510(k) clearance as of April 28, 2025 — making it the first and only FDA 510(k)-cleared 3D printed pedicle screw system in the world. “This historic achievement represents a monumental … [Read more...] about Eminent Spine’s 3D Printed Titanium Pedicle Screw System Receives Groundbreaking FDA 510(k) Clearance. The Future of Fusion Has Arrived.

HUNTSVILLE, Ala., May 6, 2025 (Newswire.com) - Curiteva, a leader in 3D-printed Trabecular PEEK implant technology, is pleased to announce an expanded partnership with Promimic, pioneers in nanotechnology, delivering advanced implant solutions with unmatched capabilities. The partnership combines Promimic's groundbreaking surface modification with Curiteva's innovative … [Read more...] about Curiteva & Promimic – Bonded by Innovation

The latest results from Johnson & Johnson’s “Spine, Sports & Other” segment raise more questions than answers, especially for those of us closely watching the spine market.Over the last five quarters, the business has shown little change, with no clear growth trend. In fact, it ended Q1 2025 with the same sales figure as Q1 2024—$752 million. On the surface, that might … [Read more...] about J&J’s Spine Business—Stability Amid Uncertainty?

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended March 31, 2025, and recent corporate highlights. Recent Highlights “ATEC exists to revolutionize spine surgery, and our Q1 results show that our … [Read more...] about ATEC Reports First Quarter 2025 Financial Results and Raises Full-Year Guidance

Bethesda, Maryland Apr 29, 2025 (Issuewire.com)  - ComboSpine™, a medical device company reshaping spinal fusion procedures with its innovative DEX360™ disc preparation and implant system, today announced the appointment of Craig Corrance as Chief Executive Officer. Corrance brings over three decades of experience in the global orthopedic device industry, with the last 20 years … [Read more...] about ComboSpine Appoints Spine Veteran Craig Corrance as Chief Executive Officer

WEST CHESTER, Pa., April 29, 2025 /PRNewswire/ -- Centinel Spine®, LLC ("the Company"), the leading global medical device company focused exclusively on treating cervical and lumbar spinal disease with the most complete and clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®), today announced achievement of nearly $28 … [Read more...] about Centinel Spine® prodisc® Total Disc Replacement Grows 33% Worldwide in First Quarter 2025, Surpassing $100M in Trailing Twelve Months Revenue

Dr. John Webb, a distinguished British spine surgeon and former physician to the Royal Family, is at the center of a legal dispute with U.S. medical giant Johnson & Johnson. Now aged 82, Webb is seeking compensation he says is rightfully owed for his role in developing groundbreaking spinal implants. According to a report by the Daily Mail, the dispute traces back to the … [Read more...] about Dispute Over Spinal Implant Royalties Between British Surgeons and Johnson & Johnson

New York, NY, April 24, 2025 - In a pivotal move shaping the future of MedTech, Tyber Medical, Intech, and Resolve Surgical Technologies have merged into a unified, leading developer, designer and manufacturer of surgical devices focused on serving the needs of MedTech OEMs and patients. The new group combines world-class implant and … [Read more...] about Tyber, Intech & Resolve Finalize Merger to Form Global CDMO+ for Musculoskeletal Device Solutions

SEOUL, South Korea — CGBIO(CEO Hyun Seung Yu), a leading Korean company specializing in bio-regenerative medicine, proudly announces that its innovative bone graft substitute, NOVOSIS PUTTY, has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA). This pivotal approval paves the way for a clinical trial in spinal fusion … [Read more...] about CGBIO Receives FDA IDE Approval for NOVOSIS PUTTY, Advancing Toward U.S. Market Entry

BERN, Switzerland, April 24, 2025 (Newswire.com) - LEM Surgical, a developer of advanced robotic technologies for hard tissue surgery, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its Dynamis Robotic Surgical System, marking a significant milestone in the evolution of robotic-assisted hard tissue surgery. The … [Read more...] about LEM Surgical Announces FDA Clearance of Dynamis Robotic Surgical System

Mont Saint-Guibert, Belgium, April 22, 2025 – Novadip Biosciences, a late-stage clinical biotechnology company specializing in regenerative medicine, today announces positive results from its NVDX3 program, an allogenic bone grafting material created from human osteogenic adipose tissue-derived mesenchymal stem cells (ASCs). NVDX3 performed well in an animal model with … [Read more...] about Novadip reports key nonclinical and interim clinical data for NVDX3, its off-the-shelf allogenic product, in spine fusion